| Immunology of COVID-19: current state of the science N Vabret, GJ Britton, C Gruber, S Hegde, J Kim, M Kuksin, R Levantovsky, ... Immunity 52 (6), 910-941, 2020 | 1689 | 2020 |
| In vivo suppressive function of myeloid‐derived suppressor cells is limited to the inflammatory site JM Haverkamp, SA Crist, BD Elzey, C Cimen, TL Ratliff European journal of immunology 41 (3), 749-759, 2011 | 163 | 2011 |
| Shared immunogenic poly-epitope frameshift mutations in microsatellite unstable tumors V Roudko, CC Bozkus, T Orfanelli, CB McClain, C Carr, T O’Donnell, ... Cell 183 (6), 1634-1649. e17, 2020 | 138 | 2020 |
| Profiling SARS-CoV-2 HLA-I peptidome reveals T cell epitopes from out-of-frame ORFs S Weingarten-Gabbay, S Klaeger, S Sarkizova, LR Pearlman, DY Chen, ... Cell 184 (15), 3962-3980. e17, 2021 | 109 | 2021 |
| Expression of cationic amino acid transporter 2 is required for myeloid-derived suppressor cell–mediated control of T cell immunity C Cimen Bozkus, BD Elzey, SA Crist, LG Ellies, TL Ratliff The Journal of Immunology 195 (11), 5237-5250, 2015 | 97 | 2015 |
| Immune checkpoint blockade enhances shared neoantigen-induced T-cell immunity directed against mutated calreticulin in myeloproliferative neoplasms C Cimen Bozkus, V Roudko, JP Finnigan, J Mascarenhas, R Hoffman, ... Cancer discovery 9 (9), 1192-1207, 2019 | 80 | 2019 |
| Advancing scientific knowledge in times of pandemics N Vabret, R Samstein, N Fernandez, M Merad, ... Nature Reviews Immunology 20 (6), 338-338, 2020 | 54 | 2020 |
| Downregulation of exhausted cytotoxic T cells in gene expression networks of multisystem inflammatory syndrome in children ND Beckmann, PH Comella, E Cheng, L Lepow, AG Beckmann, SR Tyler, ... Nature communications 12 (1), 4854, 2021 | 52 | 2021 |
| Lynch Syndrome and MSI-H cancers: from mechanisms to “off-the-shelf” cancer vaccines V Roudko, C Cimen Bozkus, B Greenbaum, A Lucas, R Samstein, ... Frontiers in Immunology, 3946, 2021 | 48 | 2021 |
| Molecular states during acute COVID-19 reveal distinct etiologies of long-term sequelae RC Thompson, NW Simons, L Wilkins, E Cheng, DM Del Valle, ... Nature Medicine 29 (1), 236-246, 2023 | 35 | 2023 |
| Sampling the host response to SARS-CoV-2 in hospitals under siege AW Charney, NW Simons, K Mouskas, L Lepow, E Cheng, J Le Berichel, ... Nature Medicine 26 (8), 1157-1158, 2020 | 31 | 2020 |
| A T-cell-based immunogenicity protocol for evaluating human antigen-specific responses CC Bozkus, AB Blazquez, T Enokida, N Bhardwaj STAR protocols 2 (3), 100758, 2021 | 22 | 2021 |
| PD-1 inhibition in advanced myeloproliferative neoplasms G Hobbs, C Cimen Bozkus, E Moshier, M Dougherty, M Bar-Natan, ... Blood Advances 5 (23), 5086-5097, 2021 | 18 | 2021 |
| SARS-CoV-2-specific T cells without antibodies CC Bozkus Nature Reviews Immunology 20 (8), 463-463, 2020 | 14 | 2020 |
| Widespread immunogenic poly-epitope frameshift mutations in microsatellite unstable tumors V Roudko, CC Bozkus, T Orfanelli, SV Blank, B Greenbaum, N Bhardwaj BioRxiv, 662262, 2019 | 14 | 2019 |
| Immune escape and resistance to immunotherapy in mismatch repair deficient tumors G Mestrallet, M Brown, CC Bozkus, N Bhardwaj Frontiers in Immunology 14, 1210164, 2023 | 12 | 2023 |
| Calreticulin mutant myeloproliferative neoplasms induce MHC-I skewing, which can be overcome by an optimized peptide cancer vaccine M Gigoux, MO Holmström, R Zappasodi, JJ Park, S Pourpe, CC Bozkus, ... Science translational medicine 14 (649), eaba4380, 2022 | 11 | 2022 |
| Immune checkpoint blockade enhances mutated calreticulin-induced t cell immunity in myeloproliferative neoplasms CC Bozkus, JP Finnigan, J Mascarenhas, R Hoffman, N Bhardwaj, ... Blood 130, 384, 2017 | 6 | 2017 |
| Advancing T cell–based cancer therapy with single-cell technologies SL Bucktrout, NE Banovich, LH Butterfield, C Cimen-Bozkus, JR Giles, ... Nature medicine 28 (9), 1761-1764, 2022 | 4 | 2022 |
| Results of a phase II study of PD-1 inhibition in advanced myeloproliferative neoplasms GS Hobbs, CC Bozkus, M Wadleigh, L Sandy, M Doughtery, K Johnson, ... Blood 136, 14-15, 2020 | 4 | 2020 |
